Danielle Schroeder
Internal Medicine · Gallatin, TNNPI 1093164550
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 30.4% of the total. Reporting peaked in 2023 at $1,555 and has fallen 97.9% since, to $32 in 2025.
Across 123 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$705
- Novo Nordisk$294
- GSK$197
- AstraZeneca$175
- Lilly USA, LLC$117
- Novartis$101
- plus $730 from 24 others
What the payments were for
- Food & beverage$2,319100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 46 | $705 |
| Novo Nordisk | 10 | $294 |
| GSK | 6 | $197 |
| AstraZeneca | 10 | $175 |
| Lilly USA, LLC | 7 | $117 |
| Novartis | 5 | $101 |
| Amgen(2 entities) | 5 | $86 |
| Lundbeck LLC | 2 | $49 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Alkermes, Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $41 |
| Exact Sciences | 2 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Pfizer | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Baxter Healthcare | 1 | $23 |
| Nevro Corp. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Ardelyx, Inc. | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Bausch Health US, LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Merck | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $12 |
| GRT US Holding, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$125
- VRAYLAR$123
- TRELEGY ELLIPTA$122
- Wegovy$116
How this compares
$2,319 in reported general payments places this provider in the 75th percentile of 2,216 internal medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $560 |
| Ipratropium Bromide | 22 | $491 |
| Bupropion Hcl SrBupropion Hcl | 11 | $385 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $342 |
| Atorvastatin Calcium | 16 | $287 |
| Alendronate Sodium | 14 | $262 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $248 |
| Levothyroxine Sodium | 16 | $216 |
| Famotidine | 14 | $169 |
| Amlodipine Besylate | 15 | $105 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Gallatin
- John AndersonNashville$1.5M
- Tracie WalkerJackson$488K
- Nathan TrenthamEtowah$404K
- Dennis DeruelleKnoxville$263K
- Devin ShermanFranklin$191K
- Lewis HagoodKnoxville$143K
- Temidayo AbeNashville$113K
- Kenya KozawaSweetwater$86K
- Wayne RileyNashville$86K
- Maighan SeagroveChattanooga$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.